We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 283

Antitrust Quarterly - Winter 2013
  • Greenberg Traurig LLP
  • USA
  • February 28 2013

"Together we discovered that a free market only thrives when there are rules to ensure competition and fair play." President Barack Obama, January


Recent FTC enforcement action reinforces narrow ‘passive investor' exemption to HSR reporting requirements
  • Greenberg Traurig LLP
  • USA
  • December 6 2012

On September 25, 2012, Biglari Holdings, Inc. agreed to pay a civil fine of $850,000 to resolve Federal Trade Commission (FTC) contentions that it improperly relied upon the "passive investor" exemption to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act") in connection with its investment in Cracker Barrel Old Country Store, Inc. during the summer of 2011


Pharmaceutical patent transfers subject to the HSR Act: increased review raises importance of valuation
  • Greenberg Traurig LLP
  • USA
  • December 6 2012

Proposed Amendments to the Rules under the Hart Scott Rodino Act ("HSR Act") would require compliance with the Act's reporting and waiting period requirements for certain acquisitions of exclusive pharmaceutical patent licenses that historically have not been reportable because the licensor retained manufacturing rights under the patent


Antitrust Quarterly - Spring 2013
  • Greenberg Traurig LLP
  • USA
  • May 31 2013

On April 8, 2013, the Federal Trade Commission (FTC) released a proposed complaint and Consent Order against Bosley, Inc. and its corporate parents


EU merger control: reform with a small "r" (but do not underestimate its value)
  • Greenberg Traurig LLP
  • European Union
  • February 28 2013

As many businesses will be acutely aware, the preparation of merger control notifications to the European Commission (the "Commission") under the EU


The European private enforcement regime reaches a milestone
  • Greenberg Traurig LLP
  • European Union
  • May 20 2014

On April 17, 2014, the European Parliament approved the European Commission's (Commission) proposal for a Directive on damages actions for


Heartburn for drug manufacturers: 'reverse payment' that did not include a monetary payment held actionable under the antitrust laws
  • Greenberg Traurig LLP
  • USA
  • November 18 2013

On July 17, 2013, the Supreme Court of the United States resolved a decade of conflicting circuit court decisions in FTC v. Actavis, Inc., ruling


Beware: enterprises facilitating, but not operating in, a cartelized market can be fined for participating in the cartel
  • Greenberg Traurig LLP
  • European Union
  • May 20 2014

A recent ruling of the General Court of the European Union (GC) affirmed that enterprises that are not active in the same market as other cartel


Antitrust damages in civil actions: will the new directive open the floodgates?
  • Greenberg Traurig LLP
  • European Union
  • February 12 2015

On Dec. 26, 2014, the Directive 2014104EU on certain rules governing actions for damages under national law for infringements of the competition


Revised Clayton ActHart-Scott-Rodino premerger notification thresholds for 2015
  • Greenberg Traurig LLP
  • USA
  • February 12 2015

On Jan. 15, 2015, the Federal Trade Commission (FTC) announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds under which transactions will